AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Item 9 Labs Corp.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0 - $0
Market Cap
70.18K
AVG Volume
20.52K
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-12-02
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
010M20M30M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q319.69M
23 Q219.6M
23 Q120.57M
22 Q421.76M
22 Q323.85M
22 Q225.61M
22 Q125.08M
21 Q421.94M
21 Q318.36M
21 Q213.88M
Net Income (USD) · TTM
-40M-30M-20M-10M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q3-31.01M
23 Q2-30.57M
23 Q1-31.04M
22 Q4-31.14M
22 Q3-21.73M
22 Q2-17.1M
22 Q1-13.18M
21 Q4-10.91M
21 Q3-9M
21 Q2-9.77M
Operating Income (USD) · TTM
-30M-20M-10M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q3-20.16M
23 Q2-21.04M
23 Q1-22.52M
22 Q4-23.07M
22 Q3-14.26M
22 Q2-10.66M
22 Q1-7.37M
21 Q4-5.6M
21 Q3-3.18M
21 Q2-3.18M
EBITDA (USD) · TTM
-30M-20M-10M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q3-19.83M
23 Q2-20.65M
23 Q1-22.09M
22 Q4-22.83M
22 Q3-12.04M
22 Q2-8.77M
22 Q1-5.84M
21 Q4-4.35M
21 Q3-2.63M
21 Q2-2.55M
Cash Flows (USD) · TTM
-10M-7.5M-5M-2.5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q3-2.6M
23 Q2-4.76M
23 Q1-6.29M
22 Q4-7.71M
22 Q3-5.2M
22 Q2-7.05M
22 Q1-8.6M
21 Q4-8.28M
21 Q3-9.4M
21 Q2-6.06M
EPS (USD) · TTM
-0.4-0.3-0.2-0.1-021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q3-0.31
23 Q2-0.31
23 Q1-0.32
22 Q4-0.32
22 Q3-0.23
22 Q2-0.18
22 Q1-0.14
21 Q4-0.12
21 Q3-0.15
21 Q2-0.16
Expenses (USD) · TTM
010M20M30MSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q319.38M
23 Q219.53M
23 Q121.89M
22 Q424.29M
22 Q320.74M
22 Q220.99M
22 Q117.15M
21 Q413.35M
21 Q310.81M
21 Q27.94M
Shares Outstanding (USD) · TTM
-4M-3M-2M-1M0Buybacks (Repurchases)Stock-Based Compensation21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
INLB Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q3-2.84M
23 Q2-2.91M
23 Q1-3.54M
22 Q4-3M
22 Q3-3.33M
22 Q2-2.7M
22 Q1-1.92M
21 Q4-1.72M
21 Q3-1.17M
21 Q2-868.98K
Employee Count
0501001502012201320142019202020212022
INLB Employee Count by quarter
PeriodEmployee Count
202297
2021103
202072
201967
20142
20132
20122
Free Cash Flow Yield
-3000000%-2000000%-1000000%0%med -25502.61%Jan 25May 25Sep 25Jan 26May 26Sep 26
INLB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-25502.61%
Sep 26-25502.61%
Aug 26-25502.61%
Aug 26-25502.61%
Aug 26-25502.61%
Aug 26-25502.61%
Jul 26-25502.61%
Jul 26-25502.61%
Jul 26-25502.61%
Jul 26-25502.61%
Jul 26-25502.61%
Jun 26-25502.61%
Jun 26-25502.61%
Jun 26-2550261.16%
Jun 26-25502.61%
May 26-25502.61%
May 26-25502.61%
May 26-25502.61%
May 26-25502.61%
May 26-25502.61%
Apr 26-25502.61%
Apr 26-25502.61%
Apr 26-25502.61%
Apr 26-25502.61%
Mar 26-25502.61%
Mar 26-25502.61%
Mar 26-25502.61%
Mar 26-25502.61%
Feb 26-25502.61%
Feb 26-25502.61%
Feb 26-25502.61%
Feb 26-25502.61%
Jan 26-25502.61%
Jan 26-25502.61%
Jan 26-25502.61%
Jan 26-25502.61%
Jan 26-25502.61%
Dec 25-25502.61%
Dec 25-25502.61%
Dec 25-25502.61%
Dec 25-25502.61%
Nov 25-25502.61%
Nov 25-25502.61%
Nov 25-2550261.16%
Nov 25-25502.61%
Oct 25-25502.61%
Oct 25-25502.61%
Oct 25-25502.61%
Oct 25-25502.61%
Oct 25-25502.61%
Sep 25-2550261.16%
Sep 25-2550261.16%
Sep 25-25502.61%
Sep 25-25502.61%
Aug 25-25502.61%
Aug 25-25502.61%
Aug 25-25502.61%
Aug 25-25502.61%
Aug 25-2550261.16%
Jul 25-25502.61%
Jul 25-25502.61%
Jul 25-25502.61%
Jul 25-25502.61%
Jun 25-25502.61%
Jun 25-25502.61%
Jun 25-25502.61%
Jun 25-2550261.16%
May 25-25502.61%
May 25-25502.61%
May 25-25502.61%
May 25-25502.61%
May 25-25502.61%
Apr 25-25502.61%
Apr 25-25502.61%
Apr 25-25502.61%
Apr 25-25502.61%
Mar 25-25502.61%
Mar 25-25502.61%
Mar 25-25502.61%
Mar 25-25502.61%
Feb 25-25502.61%
Feb 25-25502.61%
Feb 25-25502.61%
Feb 25-25502.61%
Jan 25-25502.61%
Jan 25-25502.61%
Jan 25-25502.61%
Jan 25-25502.61%
Jan 25-25502.61%
Dec 24-2550261.16%
Dec 24-25502.61%
Dec 24-25502.61%
Dec 24-25502.61%
Nov 24-2550261.16%
Nov 24-25502.61%
Nov 24-25502.61%
Jul 24-2550261.16%
Jun 24-2550261.16%
Jun 24-2550261.16%
Jun 24-2550261.16%
Price to Sales
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
INLB Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Jul 240
Jun 240
Jun 240
Jun 240
EV/EBITDA
200225250275300med 242.35Jan 18Jan 18Feb 18Feb 18Mar 18Mar 18Mar 18
INLB EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 18285.95
Mar 18259.92
Mar 18207.86
Mar 18201.36
Mar 18207.86
Feb 18214.37
Feb 18220.88
Feb 18259.92
Feb 18233.89
Jan 18233.89
Jan 18259.92
Jan 18265.13
Jan 18250.81
Dec 17259.92
Price/Operating Cashflow
0200400600med 56.37Jan 18Feb 18Apr 18May 18Jun 18Aug 18Sep 18
INLB Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 18342.51
Sep 18476.08
Sep 18409.29
Aug 18476.08
Aug 18477.8
Aug 18345.93
Aug 18342.51
Aug 18342.51
Jul 18380.18
Jul 18376.76
Jul 18411.01
Jul 18411.01
Jun 18479.51
Jun 1860.36
Jun 1860.4
Jun 1856.37
Jun 1856.37
May 1856.33
May 1850.33
May 1848.32
May 1860.4
Apr 1884.56
Apr 1864.43
Apr 1848.32
Apr 1856.37
Mar 1817.27
Mar 1815.11
Mar 1810.79
Mar 1810.25
Mar 1810.79
Feb 1811.33
Feb 1811.87
Feb 1815.11
Feb 1812.95
Jan 1812.95
Jan 1815.11
Jan 1815.54
Jan 1814.36
Dec 1715.11
Price to Book
00000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
INLB Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Jul 240
Jun 240
Jun 240
Jun 240
Item 9 Labs Corp.
INLB
Stockpicker

Video analysis: INLB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.